Pre-therapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of post-therapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type

SF Leung, AT Chan, B Zee, B Ma, LY Chan, Philip Johnson, YM Lo

Research output: Contribution to journalArticle

110 Citations (Scopus)
Original languageEnglish
Pages (from-to)288-291
Number of pages4
JournalCancer
Volume98
Issue number2
DOIs
Publication statusPublished - 15 Jul 2003

Cite this